Understanding diabetes in patients with HIV/AIDS
- PMID: 21232158
- PMCID: PMC3025836
- DOI: 10.1186/1758-5996-3-2
Understanding diabetes in patients with HIV/AIDS
Abstract
This paper reviews the incidence, pathogenetic mechanisms and management strategies of diabetes mellitus in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). It classifies patients based on the aetiopathogenetic mechanisms, and proposes rational methods of management of the condition, based on aetiopathogenesis and concomitant pharmacotherapy.
References
-
- HIV Data. http://www.unaids.org/en/KnowledgeCentre/HIVData/default.asp Accessed 22 December, 2010.
-
- Young F, Critchley JA, Johnstone LK, Unwin LC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health. 2009;5:9. doi: 10.1186/1744-8603-5-9. - DOI - PMC - PubMed
-
- Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Federation and Adult treatment Panel III criteria. Diabetes Care. 2007;30(1):113–115. doi: 10.2337/dc06-1075. - DOI - PubMed
-
- De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad'A, Fontas E, Law MG, Friss-Moller N, Phillips A. Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Diabetes Care. 2008;31(6):1224–9. doi: 10.2337/dc07-2013. - DOI - PMC - PubMed
-
- Fichtenbaum CJ, Hadigan CM, Kotler DP, Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. IAPAC Monthly. 2005. pp. 38–46. - PubMed
LinkOut - more resources
Full Text Sources
